Biosimilar Drugs Underutilized Due to Commercial Insurance Restrictions
The first study to examine biosimilar drivers finds commercial insurers limit use in almost 20% of cases.
Schaeffer Research Director Testifies at Congressional Hearing on Biomedical Innovation and Patient Access
Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.
Medicare Coverage of Weight Loss Drugs Could Significantly Reduce Costs
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
New Schaeffer White Paper Offers Solutions to Ensure Greater Patient Access to Prescription Drugs
The researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
Medicare Advantage Enrollment Outpaces —and Nearly Overcomes— Traditional Medicare, New USC Study Finds
Medicare Advantage plans have seen a more than 300% increase in enrollment—with payment policy yet to catch up.
False Confidence in Blood Pressure Knowledge Undermines Intentions to Seek Care
Most Americans don’t know the meaning of 120-80 mm Hg, but think they do.
New Randomized Trial Shows Simple Letters Promote Better-Informed Opioid Prescribing
Letters successfully encouraged clinicians to check patients’ prescribing records, says study co-author Mireille Jacobson.
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Traditional Vaccination Playbook Doesn’t Work with COVID
New study finds financial incentives and other behavioral nudges made little difference among certain groups.